仙乐健康筹划发行H股股票并在香港联交所上市

Core Viewpoint - The company, Xianle Health, aims to enhance its global strategy by issuing H-shares and listing on the Hong Kong Stock Exchange to strengthen its capital and competitive position [1] Group 1 - The company plans to deepen its global strategic layout by leveraging international capital market advantages [1] - The issuance of H-shares is intended to create a diversified capital operation platform [1] - The goal is to improve the company's capital strength and overall competitiveness [1] Group 2 - The initiative is expected to accelerate the development of the company's overseas business [1] - The company aims to establish a complete domestic and international dual circulation pattern [1] - This move is designed to consolidate the company's position within the industry [1]